Aptar Pharma is the Aptargroup business segment dedicated to meeting the evolving needs of biotechnology, healthcare and pharmaceutical companies with innovative drug delivery solutions.
With a strong focus on leveraging innovation to provide patient-focused solutions, Aptar Pharma allocates 5% of annual revenue to research and development. Aptar Pharma has manufacturing sites in Argentina, China, France, Germany, Switzerland, U.S.A and India serving the pharmaceutical industry market worldwide.
Aptar Pharma designs, develops and manufactures a comprehensive range of proprietary, innovative and user-centric delivery solutions for the biotechnology, healthcare and pharmaceutical applications.
For more information, please visit: www.aptar.com
BD Medical - Pharmaceutical Systems is a global leader in supplying the pharmaceutical industry with innovative, high-quality, clinically-proven and customized pre-fillable parenteral drug delivery systems. Our offering includes an extensive portfolio of pre-fillable syringes, self-injection systems, safety and shielding solutions designed to protect, package and deliver drug therapies and to maximize healthcare worker and patient safety.
BD Medical - Pharmaceutical Systems is a reliable partner that can provide expertise in highly specific fields to support your drug throughout its lifecycle, from development to launch and beyond. We are uniquely positioned to offer expertise in drug container interactions, primary container selection and container/device integration for a variety of drug therapies including vaccines, biopharmaceuticals, acute care drugs, anticoagulants and hyaluronic acid. We are committed to building a partnership with you and developing product solutions that meet your needs by leveraging our innovative technologies, extensive global manufacturing and advanced technical, scientific, medical and regulatory expertise.
For more information, please visit: www.bd.com
USP is an independent non-profit organization that collaborates with the world’s top health and science experts to develop high-quality standards that set the bar for manufacturing and distributing safe and effective medicines, supplements and food around the globe. Two billion people world-wide have access to quality medicines, dietary supplements and food as a result of USP’s standards, advocacy and education.
At USP Biologics our primary objective is to keep you at the vanguard of standards that promote the quality of biological medicines. We do this through our rigorous and proven scientific process. And we place the outcome of our process – the physical standard as well as the method or supporting information– into your hands.
We provide a trusted, independent, single source of reliable standards that are available and used globally. Building upon our successes with more traditional biologics including Insulin and Heparin, we engage with thousands of experts, professionals, associations, regulatory agencies, and companies to pave the way for higher standards for the new wave of biologics and biosimilar drugs. It’s logical really: by actively working with the scientific community and making our rigorously researched standards available to the world, we enable you to provide access to quality medicines for all. Through a collaborative process and commitment to quality, our USP’s biologic standards help by delivering key tools and resources to help make critical medicines, such as the insulin family of products, more accessible to the global population.
To assist you in achieving high standards in drug validation and regulatory compliance as well as avoiding potentially costly mistakes, choose our globally renowned scientific approach that has provided trustworthy standards for decades. Logical really. Our process is as robust as the results you will achieve.
So why not talk with us and find out how we can help advance your biologics and biosimilars project with reliable standards?
For more information, please visit: http://www.usp.org/biologics
Merck, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. Our comprehensive portfolio supports customers during all stages of the drug manufacturing process. With our broad range of products, applications and services including single-use manufacturing, filtration, chromatography and purification, virus reduction, pharma and biopharma raw materials, drug delivery compounds, and engineering and validation services we are committed to best support your goals of intensified, connected or continuous bioprocessing. Our industry expertise and regulatory know-how help you get to clinic faster, allowing you to focus on what matters most — delivering safe, effective therapies sooner to the patients that need them most.
For more information, please visit: MerckMillipore.com/BioContinuum
Envirotainer is the global market leader in secure cold chain solutions for air transport of pharmaceuticals. The company develops, manufactures and offers leasing of innovative container solutions, including validation, support and service, for pharma products that require a controlled environment. Thanks to a truly global presence with the world’s largest active container fleet, the most extensive network and more than 35 years of industry expertise, Envirotainer is able to meet the customers' need for innovative and reliable solutions - available from any location to any destination. The company operates through an open, global network of airlines and forwarders and the headquarters is located outside of Stockholm, Sweden.
For more information, please visit: www.envirotainer.com
GenScript Biotech Corporation is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.
GenScript currently has more than 3000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 70 patents and over 200 patent applications. As of January 2019, GenScript's products and services have been cited by 36,500 scientific papers worldwide.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
For more information, please visit: https://www.genscript.com/
Every day, scientists around the world are tackling chronic diseases and infections at the cellular level to understand causes, identify treatments and test new drugs and vaccines. Danaher’s Life Sciences companies make this leading-edge scientific research possible at clinical research facilities, academic institutions and government agencies. Our capabilities extend beyond research with the world’s most advanced filtration, separation and purification technologies, which power the creation of biopharmaceuticals, microelectronics and more.
For more information, please visit: www.danaher.com
Contributing to Society through Healthcare,” is both Terumo’s starting point and unchanging group mission since founded in 1921. Keeping Dr. Kitasato’s spirit of innovation and challenge alive, we strive to bring outstanding innovation to medicine and enable the best possible care for patients. Among our seven business areas, Alliance Division offers pharmaceutical companies advanced devices that utilize Terumo’s experience and expertise built through years of prefilled product manufacturing. We develop administration devices (including syringe and needle) made from materials tailored to each drug, and provides contract manufacturing that leverages Terumo’s advanced manufacturing technology for drug-device combination products. Through alliances with pharmaceutical companies, the Alliance Division provides a total solution, from clinical trial drug manufacture to full commercialization, contributing to safer and more certain delivery of the drugs patients need.
For more information, please visit: www.terumo.com
Pharmaceutical companies — and other organizations looking to make significant cost and quality improvements in their cold chains — are switching to Pelican BioThermal for single-use and reusable temperature-controlled packaging. Our innovative, patented technologies and consultative services ensure product quality, mitigate excursion rates, reduce packaging costs and drive Total Cost of Ownership (TCO) across your entire supply chain. Our global network of consultative cold chain experts provides our customers with consistent packaging and logistics experiences wherever they do business. While our full line of single-use and reusable packaging solutions — from parcel to pallet shippers — are competitively priced, the real economic value we bring to our customers focuses on TCO.
For more information, please visit: pelicanbiothermal.com
We are a focused industrial supplier with leading positions in global and regional market segments. With a total of more than 50 operating companies, sales in over 100 countries and some 7,500 employees, we generate annual revenue of some CHF 1,300 million.
The Datwyler Sealing Solutions Division is a leading supplier of customer specific sealing, closure and packaging solutions to global market segments, such as the Automotive, Health Care, Civil Engineering and Consumer Goods industries. This is thanks to its leading material, engineering and process expertise and worldwide presence with its own production locations. As an acknowledged development partner, Datwyler maintains close working relationships with global customers, and has in-depth knowledge of the business models and technologies used in the markets in which it operates.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
For more information, please visit www.thermofisher.com.
BioSpectrum is an integrated B2B media platform for the bioscience industry in the Asia Pacific region. It engages its readers from pharma, biotech &medtech industry segments through its media products and services at daily, fortnightly and monthly frequencies across countries, in Asia.
For more information, please visit: www.biospectrumasia.com